| Literature DB >> 35081950 |
Robert J Magnani1, Dewa Nyoman Wirawan2,3, Anak Agung Sagung Sawitri2,3, I Gusti Agung Agus Mahendra2,4, Dewi Susanti2, Ni Kadek Ayu Dwi Utami Ds2, Dedison Asanab2, Jessie Olivia Yunus2, Cahyo Heri Setiabudi5, Adi Nugroho6, Asti Setiawati Widihastuti5, Oldri Sherli Mukuan5, Pande Putu Januraga7,8.
Abstract
BACKGROUND: The COVID-19 pandemic has raised concerns as to its impact on other health programs. One program that appears particularly vulnerable is HIV and AIDS. We undertook an assessment of COVID-19 impact on HIV control efforts in Indonesia for a sub-population that has received little attention in the global literature-female sex workers (FSW).Entities:
Keywords: COVID-19; HIV/AIDS program impact; Indonesia
Mesh:
Year: 2022 PMID: 35081950 PMCID: PMC8791089 DOI: 10.1186/s12905-021-01583-z
Source DB: PubMed Journal: BMC Womens Health ISSN: 1472-6874 Impact factor: 2.809
Fig. 1Monthly COVID-19 infection rates per 1000 population in study districts
Fig. 2Trends in commercial sex activity and HIV testing service availability in 23 districts, January–July 2020
District-level changes in commercial sex activity and HIV testing service availability, January–July 2020
| Indicator | Highest number | Lowest number | % Reduction | ||||
|---|---|---|---|---|---|---|---|
| High | Month | Low | Month | Aggregate* | Largest | Smallest | |
| No. Localization areas still open | 589 | February | 251 | April | 57 | 100 | 0 |
| No. FSW still working—Localization Areas | 2955 | February | 1015 | April | 66 | 100 | 35 |
| No. client transactions—Localization | 3760 | February | 906 | April | 76 | 100 | 14 |
| No. Non-Localization areas still open | 1415 | February | 213 | April | 86 | 100 | 30 |
| No. FSW still working—Non-localization | 11,042 | January | 1236 | April | 89 | 100 | 6 |
| No. client transactions—Non-localization | 16,382 | February | 1244 | April | 92 | 100 | 52 |
| No. health facilities providing HIV testing | 297 | February | 141 | April | 53 | 100 | 20 |
| No. mobile clinics providing HIV testing | 252 | February | 0 | April | 100 | 100 | 0 |
*All magnitudes of decline were statistically significant at the p < .01 level or greater in paired t-tests for repeated measures data
Fig. 3Monthly community outreach and HIV testing result for FSW in 23 districts, January–July 2020
HIV case finding and treatment initiation rates among FSW in 23 districts, by month, January–July 2020
| Service output | 2019 | 2020 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 1st Semester | 2nd Semester | Jan | Feb | Mar | Apr | May | Jun | Jul | |
| Number HIV cases detected | 31 | 34 | 20 | 48 | 41 | 16 | 8 | 19 | 34 |
| Number initiating treatment | 16 | 26 | 21 | 32 | 30 | 16 | 2 | 17 | 29 |
| % Initiating treatment | 52 | 76 | 105 | 67 | 73 | 100 | 25 | 89 | 85 |
District-level changes in FSW HIV program outputs, January–July 2020
| Indicator | Highest number | Lowest number | % Reduction | ||||
|---|---|---|---|---|---|---|---|
| High | Month | Low | Month | Aggregate* | Largest | Smallest | |
| No. FSW reached | 6485 | February | 2786 | May | 57 | 91 | 11 |
| No. FSW tested for HIV | 3114 | February | 474 | May | 85 | 100 | 76 |
| No. Condoms distributed | 38,885 | February | 16,375 | May | 62 | 100 | 0 |
| No. HIV + cases detected | 48 | February | 8 | May | 83 | 100 | 67 |
| No. HIV + FSW initiating ARV | 32 | March | 2 | May | 94 | 100 | 89 |
*All magnitudes of decline were statistically significant at the p < .001 level or greater in paired t-tests for repeated measures data
Fig. 4Proportion of FSW initiating treatment in the prior 3 months who were still on treatment, by month, January–July 2020
Community HIV screening, April–July 2020
| Indicator | Month | Total | |||
|---|---|---|---|---|---|
| Apr | May | Jun | Jul | ||
| No. FSW tested for HIV | 47 | 203 | 539 | 326 | 1115 |
| No. reactive tests | 1 | 4 | 9 | 11 | 25 |
| Positivity rate | 2.1 | 2 | 1.7 | 3.4 | 2.0 |
| No. HIV + receiving confirmatory test | 1 | 1 | 6 | 7 | 15 |
| Pct. HIV + receiving confirmatory test | 100 | 25 | 66.7 | 63.6 | 60 |
| No. with confirmatory reactive results | 1 | 1 | 6 | 7 | 15 |
| Pct. with reactive confirmatory test | 100 | 100 | 100 | 100 | 100 |
| No. confirmed HIV + initiating ART | 1 | 1 | 4 | 6 | 12 |
| Pct. initiating treatment | 100 | 100 | 66.7 | 85.7 | 80 |